|
|
|
|
|
|
|
|
|
|
|
Nobivac Feline 1-HCP, by Merck, vaccine is a modified live virus vaccine for protection against feline rhinotracheitis (feline herpes), calici and panleukopenia (feline distemper) viruses. Give 1 ml SQ or IM to cats 9 weeks of age or older. Repeat with a second dose 3 to 4 weeks later. Annual revaccination with one dose is recommended. Not for pregnant queens. Nobivac Feline 1-HCP requires mixing. Order syringes separately.
|
Nobivac 1-Rabies vaccine, by Merck is for vaccination of healthy dogs and cats as an aid in preventing rabies for at least 1 year. Nobivac 1-Rabies is produced on an
|
Nobivac Feline 1-HCPCh (formerly Eclipse 4), by Merck, is a modified live virus for protection against panleukopenia (cat distemper), calici, rhinotracheitis and
|
|
|
|
|
|
|
|
|
|
|
|
|
Nobivac Feline-Bb (formally PROTEX®-Bb), by Merck, is an INTRANASAL vaccine containing an avirulent live culture of Bordetella bronchiseptica. PROTEX®-Bb is presented in a desiccated form with sterile diluent provided for reconstitution.
|
Nobivac Feline 1-HCP+FELV, by Merck, is a modified live virus vaccine for protection against feline rhinotracheitis (feline herpes), calici, panleukopenia (cat distemper)
|
Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus, non-adjuvanted, cats 8 weeks and older. Preservatives: Gentamicin and amphotericin B.
|
|
|
|
|
|
|
|
|
|
|
Nobivac Feline 1-HCPCh + FeLV, by Merck, is a modified live virus for protection against panleukopenia (cat distemper), calici, rhinotracheitis, chlamydia and feline
|
Nobivac® FeLV (Fevaxyn Felv), by Merck, is recommended for the vaccination of healthy cats as an aid in the prevention of disease associated with feline leukemia
|
|